Loading [Contrib]/a11y/accessibility-menu.js
JHSS
Menu
Articles
Original article
Review paper
All
For Authors
Editorial Board
About
Issues
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jhss.scholasticahq.com/feed
×
Review paper
March 17, 2022 CDT
Immunotherapy using CRISPR-Cas9 systems to treat rheumatoid arthritis with PTPN22 R620W mutations and target PD-1 and CD20
Aishwarya Shivaraman
,
Nicole Guilz
,
Immunotherapy
Rheumatoid arthritis
PTPN22
T cells
B cells
CRISPR/Cas9
PDCD1
PD-1
MS4A1
CD20
ccby-nc-sa-4.0
JHSS
Shivaraman, Aishwarya, and Nicole Guilz. 2022. “Immunotherapy Using CRISPR-Cas9 Systems to Treat Rheumatoid Arthritis with PTPN22 R620W Mutations and Target PD-1 and CD20.”
Journal of High School Science
, March.
Save article as...
▾
PDF
XML
Citation (BibTeX)